At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Echocardiographic Changes During Adjuvant Therapy in Hispanic Women With Her-2 Neu Expressing Breast Cancer
Texas Tech University Health Sciences Center, El Paso·observational·Posted Apr 21, 2017·Updated Sep 9, 2019
In Brief
An observational study for Breast Cancer. Completed, enrolled 60 participants across 1 site.
Detailed Summary
This study retrospectively looks at changes in Echocardiographic parameters while using transtuzumab
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartApr 2017
First PostedApr 2017
Primary CompletionFeb 2019
TodayJul 2026
First PostedApr 21, 2017
Enrollment StartApr 11, 2017
Primary CompletionFeb 26, 2019
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 9.2 years ago